Expression of astrocyte‐elevated gene‐1 indicates prognostic value of fluoropyrimidine‐based adjuvant chemotherapy in resectable stage III colorectal cancer

It is unclear which prognostic factor such as pathological features and gene mutation are majorly relevant for stage III disease and whether they aid in determining patients who will be benefit from postoperative adjuvant chemotherapy. The expression of astrocyte‐elevated gene‐1 (AEG‐1), thymidylate synthase (TS), excision repair cross‐complementation group 1 (ERCC1), epidermal growth factor receptor (EGFR), and vascular endothelial growth...